ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

YS YS Biopharma Company Ltd

0.9279
-0.0241 (-2.53%)
May 10 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
YS Biopharma Company Ltd YS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0241 -2.53% 0.9279 23:00:11
Open Price Low Price High Price Close Price Previous Close
0.988 0.90 0.9976 0.97 0.952
more quote information »

Recent News

Date Time Source Heading
5/07/202415:20PRNUSYS Biopharma to Hold Extraordinary General Meeting on May..
4/29/202407:00PRNUSYS Biopharma Receives Additional 180 Day Extension by Nasdaq..
4/19/202406:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
4/18/202407:00PRNUSYS Biopharma Granted Phase I Clinical Trial License of..
4/16/202407:00PRNUSYS Biopharma to Report First Nine Months of Fiscal Year 2024..
4/09/202407:00PRNUSYS Biopharma Announces Positive Interim Results of Pivotal..
4/03/202407:00PRNUSYS Biopharma Announces Full Repayment of US$40,000,000 Loan..
3/05/202407:00PRNUSYS Biopharma Announces Board Changes and Strategic..
2/22/202416:00PRNUSYS Biopharma Announces Results of Extraordinary General..
2/18/202403:30PRNUS/C O R R E C T I O N -- YS Biopharma Co., Ltd./
2/16/202419:20PRNUSYS Biopharma Announces Results of Extraordinary General..
2/14/202407:00PRNUSYS Biopharma to Hold an Extraordinary General Meeting on..
2/14/202406:50PRNUSYS Biopharma Announces Appointment of New Directors
2/12/202407:50PRNUSYS Biopharma Responds to a Notice of Extraordinary General..
2/09/202405:30PRNUSYS Biopharma Announces US$40 Million Private Placement..
2/08/202417:10PRNUSShareholders of YS Biopharma Announce an Extraordinary..
1/22/202416:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
1/08/202407:00PRNUSYS Biopharma Announces Changes to its Board Committees
12/20/202315:30PRNUSYS Biopharma Responds to Unauthorized Press Release..
12/20/202307:56PRNUSYS Biopharma Co., Ltd. to Hold Extraordinary General Meeting..
11/14/202307:30PRNUSNoble Capital Markets Initiates Coverage on YS Biopharma..
10/31/202307:30PRNUSYS Biopharma Announces Completion of Subject Enrollment in..
10/26/202307:30PRNUSYS Biopharma Announces Receipt of Nasdaq Notice
9/26/202307:30PRNUSYS Biopharma Announces First Subject Enrollment in Pivotal..
9/15/202307:30PRNUSYS Biopharma Granted Patent in the U.S. for Immunotherapy..
9/05/202307:30PRNUSYS Biopharma to Participate in Participate in Citi's 18th..
8/24/202315:15PRNUSYS Biopharma Announces Purchase of Shares by Company..
8/15/202316:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
7/26/202316:00PRNUSYS Biopharma Announces Financial Results for Fiscal Year..
7/21/202315:30PRNUSYS Biopharma to Report Financial Results for Fiscal Year..
6/01/202307:30PRNUSYS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical..
5/18/202307:25PRNUSYS Biopharma to Participate in the Virtual Benchmark..
5/16/202306:00PRNUSYS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical..